Paper38726429
Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.
Rauf A and 9 others. Food Sci Nutr, 2024. Cited by 6 papers, by iCite. Retracted.
Cite this record
ConductScience Library. Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study. Papers, record 38726429. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38726429
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 42775171 | RETRACTION: Hypoglycemic, Anti-Inflammatory, and Neuroprotective Potentials of Crude Methanolic Extract From Acacia Nilotica L. - Results of an In Vitro Study. | https://conductscience.org/library/papers/42775171 |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29599720 | Ethnopharmacology-A Bibliometric Analysis of a Field of Research Meandering Between Medicine and Food Science? | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29599720 | PubMed |
| 2 | 29467962 | Inflammatory responses and inflammation-associated diseases in organs. | Oncotarget | 2018 | https://conductscience.org/library/papers/29467962 | PubMed |
| 3 | 24350051 | In-vitro α amylase and glycosidase inhibitory effect of ethanolic extract of antiasthmatic drug - Shirishadi. | J Adv Pharm Technol Res | 2013 | https://conductscience.org/library/papers/24350051 | PubMed |
| 4 | 33335883 | Treating Hyperglycemia From Eryngium caeruleum M. Bieb: In-vitro α-Glucosidase, Antioxidant, in-vivo Antidiabetic and Molecular Docking-Based Approaches. | Front Chem | 2020 | https://conductscience.org/library/papers/33335883 | PubMed |
| 5 | 32226726 | Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action. | Curr Pharmacol Rep | 2019 | https://conductscience.org/library/papers/32226726 | PubMed |
| 6 | 30122972 | Medicinal plants with anti-inflammatory activities from selected countries and regions of Africa. | J Inflamm Res | 2018 | https://conductscience.org/library/papers/30122972 | PubMed |
| 7 | 20042775 | Diagnosis and classification of diabetes mellitus. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20042775 | PubMed |
| 8 | 30477749 | Pharmacoepidemiology of non-steroidal anti-inflammatory drugs. | Therapie | 2019 | https://conductscience.org/library/papers/30477749 | PubMed |
| 9 | 24872833 | Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. | Evid Based Complement Alternat Med | 2014 | https://conductscience.org/library/papers/24872833 | PubMed |
| 10 | 32941929 | Alzheimer's disease: Recent treatment strategies. | Eur J Pharmacol | 2020 | https://conductscience.org/library/papers/32941929 | PubMed |
| 11 | 23943383 | Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes. | Mol Nutr Food Res | 2014 | https://conductscience.org/library/papers/23943383 | PubMed |
| 12 | 33865830 | Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/33865830 | PubMed |
| 13 | 33207605 | Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33207605 | PubMed |
| 14 | 31740050 | Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/31740050 | PubMed |
| 15 | 28611658 | Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants. | Front Aging Neurosci | 2017 | https://conductscience.org/library/papers/28611658 | PubMed |
| 16 | 18424136 | Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. | Bioorg Med Chem Lett | 2008 | https://conductscience.org/library/papers/18424136 | PubMed |
| 17 | 11966455 | New trends in dual 5-LOX/COX inhibition. | Curr Med Chem | 2002 | https://conductscience.org/library/papers/11966455 | PubMed |
| 18 | 29551098 | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. | Prim Health Care Res Dev | 2018 | https://conductscience.org/library/papers/29551098 | PubMed |
| 19 | 23090376 | Selective inhibition of cyclooxygenase-2: risks and benefits. | Rev Bras Reumatol | 2012 | https://conductscience.org/library/papers/23090376 | PubMed |
| 20 | 23641947 | Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes. | BMC Complement Altern Med | 2013 | https://conductscience.org/library/papers/23641947 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42445685 | Exploring the Therapeutic Potential of Oenothera laciniata: Antioxidant, Anti-Hyperglycemic and Histopathological Activities Using In Vitro and In Vivo Approaches. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/42445685 | PubMed |
| 40389681 | A pharmaco-metabolomics study of Glycyrrhiza glabra, Boswellia sarca, and Acacia nilotica in acute allergic dermatitis. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40389681 | PubMed |
| 39148976 | Pharmacological evaluation and binding behavior of 4,4'-diamino-2,2'-stilbene disulfonic acid with metal ions using spectroscopic techniques. | Heliyon | 2024 | https://conductscience.org/library/papers/39148976 | PubMed |
| 38726429 | Hypoglycemic, anti-inflammatory, and neuroprotective potentials of crude methanolic extract from Acacia nilotica L. - results of an in vitro study. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/38726429 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38726429
GET https://conductscience.org/api/papers/v1/38726429/references?page=2